Oppenheimer Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.37M | Buy |
2,608
+643
| +33% | +$338K | 0.02% | 680 |
|
2025
Q1 | $1.25M | Buy |
+1,965
| New | +$1.25M | 0.02% | 668 |
|
2023
Q4 | – | Sell |
-756
| Closed | -$622K | – | 1177 |
|
2023
Q3 | $622K | Buy |
756
+22
| +3% | +$18.1K | 0.01% | 795 |
|
2023
Q2 | $527K | Buy |
734
+15
| +2% | +$10.8K | 0.01% | 850 |
|
2023
Q1 | $591K | Sell |
719
-62
| -8% | -$50.9K | 0.01% | 806 |
|
2022
Q4 | $563K | Sell |
781
-216
| -22% | -$156K | 0.01% | 821 |
|
2022
Q3 | $687K | Sell |
997
-59
| -6% | -$40.7K | 0.01% | 758 |
|
2022
Q2 | $624K | Buy |
1,056
+98
| +10% | +$57.9K | 0.01% | 797 |
|
2022
Q1 | $669K | Sell |
958
-1,841
| -66% | -$1.29M | 0.01% | 850 |
|
2021
Q4 | $1.77M | Sell |
2,799
-88
| -3% | -$55.6K | 0.02% | 592 |
|
2021
Q3 | $1.75M | Buy |
2,887
+318
| +12% | +$192K | 0.02% | 578 |
|
2021
Q2 | $1.44M | Buy |
2,569
+222
| +9% | +$124K | 0.02% | 638 |
|
2021
Q1 | $1.11M | Sell |
2,347
-23,363
| -91% | -$11.1M | 0.02% | 690 |
|
2020
Q4 | $12.4M | Buy |
25,710
+997
| +4% | +$482K | 0.21% | 121 |
|
2020
Q3 | $13.8M | Buy |
24,713
+136
| +0.6% | +$76.1K | 0.27% | 92 |
|
2020
Q2 | $15.3M | Buy |
24,577
+1,357
| +6% | +$846K | 0.32% | 75 |
|
2020
Q1 | $11.3M | Buy |
23,220
+22,739
| +4,727% | +$11.1M | 0.28% | 85 |
|
2019
Q4 | $181K | Sell |
481
-30
| -6% | -$11.3K | ﹤0.01% | 1081 |
|
2019
Q3 | $142K | Sell |
511
-5
| -1% | -$1.39K | ﹤0.01% | 1114 |
|
2019
Q2 | $162K | Sell |
516
-49
| -9% | -$15.4K | ﹤0.01% | 1098 |
|
2019
Q1 | $233K | Sell |
565
-806
| -59% | -$332K | 0.01% | 995 |
|
2018
Q4 | $512K | Sell |
1,371
-60
| -4% | -$22.4K | 0.01% | 755 |
|
2018
Q3 | $578K | Buy |
1,431
+128
| +10% | +$51.7K | 0.01% | 772 |
|
2018
Q2 | $449K | Buy |
1,303
+218
| +20% | +$75.1K | 0.01% | 826 |
|
2018
Q1 | $374K | Sell |
1,085
-9,524
| -90% | -$3.28M | 0.01% | 862 |
|
2017
Q4 | $4.75M | Hold |
10,609
| – | – | 0.13% | 184 |
|
2017
Q3 | $4.75M | Buy |
10,609
+258
| +2% | +$115K | 0.12% | 186 |
|
2017
Q2 | $5.08M | Buy |
10,351
+340
| +3% | +$167K | 0.14% | 173 |
|
2017
Q1 | $3.88M | Buy |
+10,011
| New | +$3.88M | 0.11% | 216 |
|